Injection technique Subcutaneous injection - same as other peptides
These SCFAs activate G-protein-coupled receptors on L-cells to trigger GLP-1 release
Partnering with a qualified healthcare provider in Miami is key to achieving your weight loss goals
Weight & glycemic control: robust randomized control trials (RCTs) show large, clinically meaningful weight loss and A1C reduction with semaglutide and tirzepatide for people with obesity and/or type 2 diabetes
When used in prescription form, GLP-1 injections: Enhance insulin release in response to meals, stabilizing blood sugar Slow gastric emptying, making you feel fuller for longer Reduce appetite and help curb cravings The result is a powerful reduction in daily caloric intake, which can lead to significant fat loss over time, especially when paired with supportive lifestyle changes
Your provider will also ask about your surgical history, particularly any gastrointestinal surgeries, bariatric procedures, or upcoming planned surgeries